New calcium antagonists relevance vasoselectivity calcium antagonists heterogeneous class drugs number cardiovascular disorders new generation calcium antagonists development degree selectivity vascular smooth muscle coronary vasculature verapamil nifedipine diltiazem clinical relevance vasoselectivity impact drug selection calcium antagonists important alternatives agents improved tolerance reduced incidence adverse effects place therapy comparative studies efficacy safety 